title: Chemokines as pain mediators and modulators.
abstract: OBJECTIVE
  Chemokines are central to the innate immune response following tissue damage, injury and some diseases. The function of chemokines in nervous system autoimmune diseases has been long recognized. There is also growing evidence that disease-associated or injury-induced functional expression of chemokines/receptors in both neural and nonneural elements of the peripheral nervous system play crucial roles in the pathophysiology of chronic pain.
  
  
  RESULTS
  Chemokine involvement in neuropathic pain processing has recently been established in animal models. Evidence of chemokine contribution to chronic pain includes the upregulation of monocyte chemoattractant protein-1 (MCP-1/CCL2) and its respective receptor, CCR2, in many subpopulations of sensory neurons. Activation of CCR2 by MCP-1 elicits membrane depolarization, triggers action potentials and sensitizes nociceptors via transactivation of transient receptor potential channels TRPA1 and TRPV1. Increased signaling by stromal-derived factor-1 (SDF-1/CXCL12) and its receptor, CXCR4, has been shown to contribute to chronic pain behavior. The use of specific chemokine receptor antagonists for CCR2 and CXCR4 successfully reverses nociceptive pain behavior.
  
  
  CONCLUSIONS
  Our results suggest that specific chemokines/receptors are upregulated by sensory neurons following peripheral nerve injury and appear to participate in neural signal processing leading to chronic pain states. Taken together, chemokines and their receptors are potential targets for development of novel therapeutics.
authors.affiliation: Department of Cell Biology, Loyola University - Chicago, Maywood, Illinois 60153, USA. fwhite@lumc.edu
authors.forename: Fletcher A
authors.initials: FA
authors.lastname: White
authors.forename: Natalie M
authors.initials: NM
authors.lastname: Wilson
mesh_terms: D018925:Chemokines / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D009437:Neuralgia / Q000209:etiology / Q000503:physiopathology*; D009457:Neuroglia / Q000378:metabolism; D059348:Peripheral Nerve Injuries; D019707:Receptors, Chemokine / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D018925:Chemokines; D019707:Receptors, Chemokine
references.citation: Neurosci Lett. 2008 May 30;437(2):98-102
references.pmid: 18448252
references.citation: Mol Cell Neurosci. 2008 Jan;37(1):170-7
references.pmid: 17949992
references.citation: Semin Immunol. 2003 Feb;15(1):23-32
references.pmid: 12495638
references.citation: J Neurosci. 2003 Apr 15;23(8):3221-33
references.pmid: 12716929
references.citation: Science. 2000 Feb 11;287(5455):1040-6
references.pmid: 10669416
references.citation: Eur J Neurosci. 2005 Dec;22(11):2775-82
references.pmid: 16324111
references.citation: Br J Pharmacol. 2008 May;154(2):460-70
references.pmid: 18362895
references.citation: Neuroreport. 2008 Jan 22;19(2):183-6
references.pmid: 18185105
references.citation: Neurosci Res. 2004 Apr;48(4):463-9
references.pmid: 15041200
references.citation: Brain Behav Immun. 2007 Jul;21(5):668-76
references.pmid: 17129705
references.citation: Brain Behav Immun. 2007 Jul;21(5):581-91
references.pmid: 17292584
references.citation: J Biol Chem. 1998 Sep 4;273(36):23169-75
references.pmid: 9722546
references.citation: Trends Immunol. 2001 Nov;22(11):612-7
references.pmid: 11698222
references.citation: Spine (Phila Pa 1976). 2002 May 1;27(9):911-7
references.pmid: 11979160
references.citation: Pain. 2007 Nov;132(1-2):195-205
references.pmid: 17890011
references.citation: Br J Pharmacol. 1991 Nov;104(3):765-7
references.pmid: 1797337
references.citation: J Pain. 2005 Jul;6(7):434-8
references.pmid: 15993821
references.citation: Arch Phys Med Rehabil. 1998 Dec;79(12):1560-4
references.pmid: 9862301
references.citation: Br J Pharmacol. 2006 Jan;147 Suppl 1:S232-40
references.pmid: 16402109
references.citation: J Neurochem. 2008 Jan;104(1):254-63
references.pmid: 17944871
references.citation: EMBO J. 2001 May 15;20(10):2497-507
references.pmid: 11350939
references.citation: J Neurol. 2005 Nov;252 Suppl 5:v3-9
references.pmid: 16254699
references.citation: J Neuroimmunol. 2002 Mar;124(1-2):16-28
references.pmid: 11958818
references.citation: Eur J Neurosci. 2004 Nov;20(9):2294-302
references.pmid: 15525271
references.citation: Neurology. 2003 Jul 22;61(2):279; author reply 279-80
references.pmid: 12874429
references.citation: J Neurosci. 2001 Jul 15;21(14):5027-35
references.pmid: 11438578
references.citation: Pain. 2007 May;129(1-2):64-75
references.pmid: 17123734
references.citation: Neuron. 2006 Apr 20;50(2):277-89
references.pmid: 16630838
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20151-8
references.pmid: 18083844
references.citation: Neuron. 1998 Sep;21(3):531-43
references.pmid: 9768840
references.citation: J Neurophysiol. 2006 Nov;96(5):2189-99
references.pmid: 16775210
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14092-7
references.pmid: 16174730
references.citation: Neuroscience. 2007 Nov 9;149(3):706-14
references.pmid: 17870246
references.citation: Pain. 2006 Jan;120(1-2):188-201
references.pmid: 16360279
references.citation: J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):498-502
references.pmid: 11909910
references.citation: J Neurosci. 2005 Apr 20;25(16):4052-61
references.pmid: 15843607
references.citation: Brain Res Mol Brain Res. 2005 May 20;136(1-2):23-8
references.pmid: 15893583
references.citation: Curr Opin Neurol. 2003 Oct;16(5):623-8
references.pmid: 14501847
references.citation: J Neurotrauma. 2008 May;25(5):427-48
references.pmid: 18338959
references.citation: Neurol Clin. 1998 Nov;16(4):889-98
references.pmid: 9767068
references.citation: Mol Pain. 2007 Dec 12;3:38
references.pmid: 18076762
references.citation: Annu Rev Immunol. 1994;12:593-633
references.pmid: 8011292
references.citation: Neuroscience. 2006 Oct 27;142(3):809-22
references.pmid: 16887276
references.citation: Pain. 2005 Aug;116(3):213-219
references.pmid: 15964681
references.citation: N Engl J Med. 2006 Feb 9;354(6):610-21
references.pmid: 16467548
references.citation: J Neurosci. 2007 Nov 7;27(45):12396-406
references.pmid: 17989304
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4536-41
references.pmid: 15764707
references.citation: Physiol Rev. 2002 Oct;82(4):981-1011
references.pmid: 12270950
references.citation: Eur J Neurosci. 2004 Sep;20(5):1150-60
references.pmid: 15341587
references.citation: Science. 2000 Feb 11;287(5455):1049-53
references.pmid: 10669418
references.citation: Neuron. 2000 May;26(2):523-31
references.pmid: 10839370
references.citation: J Urol. 2008 May;179(5):1857-61; discussion 1861-2
references.pmid: 18353390
references.citation: Nat Rev Drug Discov. 2005 Oct;4(10):834-44
references.pmid: 16224455
references.citation: J Neurochem. 2006 May;97(3):772-83
references.pmid: 16524371
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7947-52
references.pmid: 12808141
references.citation: Int J STD AIDS. 2006 Jul;17(7):467-72
references.pmid: 16820077
references.citation: J Neuroimmunol. 2001 May 1;116(1):29-39
references.pmid: 11311327
references.citation: Brain Res. 2000 Apr 7;861(1):105-16
references.pmid: 10751570